ScoreWhy is Medpace Holdings, Inc. ?
1
Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 48.42%
- Healthy long term growth as Net Sales has grown by an annual rate of 22.27% and Operating profit at 26.21%
- Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.04 times
2
The company has declared Positive results for the last 12 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 752.66 MM
- ROCE(HY) Highest at 162.15%
- CASH AND EQV(HY) Highest at USD 1,155.37 MM
3
With ROE of 98.27%, it has a fair valuation with a 27.96 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 26.03%, its profits have risen by 11.6% ; the PEG ratio of the company is 1.2
4
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 2.8% over the previous quarter.
5
Consistent Returns over the last 3 years
- Along with generating 26.03% returns in the last 1 year, the stock has outperformed S&P 500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Medpace Holdings, Inc. should be less than 10%
- Overall Portfolio exposure to Miscellaneous should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Medpace Holdings, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Medpace Holdings, Inc.
30.59%
0.89
45.63%
S&P 500
14.84%
1.25
12.97%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
22.27%
EBIT Growth (5y)
26.21%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.70
Sales to Capital Employed (avg)
4.45
Tax Ratio
13.49%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
97.20%
ROCE (avg)
105.06%
ROE (avg)
48.42%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
28
Industry P/E
Price to Book Value
27.96
EV to EBIT
23.11
EV to EBITDA
21.96
EV to Capital Employed
-837.12
EV to Sales
4.89
PEG Ratio
1.23
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
98.27%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 752.66 MM
ROCE(HY)
Highest at 162.15%
CASH AND EQV(HY)
Highest at USD 1,155.37 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -82.65 %
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Medpace Holdings, Inc.
Operating Cash Flow
Highest at USD 752.66 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Cash and Eqv
Highest at USD 1,155.37 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at -82.65 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
